Division of Cardiovascular Medicine, West Virginia University Heart and Vascular Institute, Morgantown, WV, USA.
Section of Electrophysiology, Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California San Diego, 9452 Medical Center Dr., MC 7411, La Jolla, CA, 92037, USA.
J Interv Card Electrophysiol. 2022 Apr;63(3):503-512. doi: 10.1007/s10840-021-00977-1. Epub 2021 Mar 16.
End-stage renal disease (ESRD) is a well-recognized risk factor for the development of sudden cardiac arrest (SCA). There is limited data on baseline characteristics and outcomes after an in-hospital SCA event in ESRD patients.
For the purpose of this study, data were obtained from the National Inpatient Sample from January 2007 to December 2017. In-hospital SCA was identified using the International Classification of Disease, 9th Revision, Clinical Modification and International Classification of Disease, 10th Revision, Clinical Modification codes of 99.60, 99.63, and 5A12012. ESRD patients were subsequently identified using codes of 585.6 and N18.6. Baseline characteristics and outcomes were compared among ESRD and non-ESRD patients in crude and propensity score (PS)-matched cohorts. Predictors of mortality in ESRD patients after an in-hospital SCA event were analyzed using a multivariate logistic regression model.
A total of 1,412,985 patients sustained in-hospital SCA during our study period. ESRD patients with in-hospital SCA were younger and had a higher burden of key co-morbidities. Mortality was similar in ESRD and non-ESRD patients in PS-matched cohort (70.4% vs. 70.7%, p = 0.45) with an overall downward trend over our study years. Advanced age, Black race, and key co-morbidities independently predicted increased mortality while prior implantable defibrillator was associated with decreased mortality in ESRD patients after an in-hospital SCA event.
In the context of in-hospital SCA, mortality is similar in ESRD and non-ESRD patients in adjusted analysis. Adequate risk factor modification could further mitigate the risk of in-hospital SCA among ESRD patients.
终末期肾病(ESRD)是发生心搏骤停(SCA)的公认危险因素。关于 ESRD 患者住院期间 SCA 事件后基线特征和结局的数据有限。
为了进行本研究,数据来自 2007 年 1 月至 2017 年 12 月的国家住院患者样本。使用国际疾病分类第 9 版临床修订版和第 10 版临床修订版的 99.60、99.63 和 5A12012 代码识别住院期间 SCA。随后使用 585.6 和 N18.6 代码识别 ESRD 患者。在未校正和倾向评分(PS)匹配队列中比较 ESRD 和非 ESRD 患者的基线特征和结局。使用多变量逻辑回归模型分析 ESRD 患者住院 SCA 后死亡的预测因素。
在研究期间,共有 1,412,985 名患者发生住院期间 SCA。患有住院 SCA 的 ESRD 患者年龄较小,且合并症负担较重。在 PS 匹配队列中,ESRD 和非 ESRD 患者的死亡率相似(70.4% vs. 70.7%,p=0.45),且在研究期间呈总体下降趋势。高龄、黑人和主要合并症独立预测死亡率增加,而植入式除颤器的使用与 ESRD 患者住院 SCA 后死亡率降低相关。
在住院 SCA 的背景下,调整分析后 ESRD 和非 ESRD 患者的死亡率相似。充分的危险因素修正可能进一步降低 ESRD 患者住院 SCA 的风险。